These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4582209)

  • 1. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of hyaline membrane disease with plasminogen. Preliminary report of a cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):195-8. PubMed ID: 788079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Am J Dis Child; 1974 Feb; 127(2):189-94. PubMed ID: 4589496
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
    Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P
    Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of hyaline membrane disease with plasminogen. A cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP; Weintraub DH; Courey NG; Patterson RJ; Jockin H; Pickren JW; Bross ID; Jung OS; Ambrus JL
    JAMA; 1977 Apr; 237(17):1837-41. PubMed ID: 321823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of steroid therapy in the prevention of respiratory distress syndrome in the newborn].
    Szabó I; Csaba I; Novák P; Drozgyik I
    Orv Hetil; 1977 Mar; 118(10):566-8. PubMed ID: 840473
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.
    Ambrus JL; Ambrus CM
    J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease).
    Sahu S
    J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations of plasminogen in newborn and premature infants].
    Potron G; Leroux B; Bertignon C; Graftiaux A
    Arch Fr Pediatr; 1972; 29(6):583-92. PubMed ID: 4672950
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of hyaline membrane disease.
    Br Med J; 1973 Apr; 2(5858):65-6. PubMed ID: 4700320
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of hyaline membrane disease.
    Ackerman BD
    Pediatr Ann; 1978 Mar; 7(3):195-200. PubMed ID: 634630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology of the respiratory distress syndrome].
    Vapaavuori EK
    Duodecim; 1971; 87(10):853-60. PubMed ID: 5105469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aqueous estrogens in the management of respiratory distress syndrome.
    Shanklin DR; Wolfson SL
    J Reprod Med; 1970 Aug; 5(2):53-71. PubMed ID: 4330066
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of idiopathic respiratory distress (hyaline membrane disease)].
    Amiel-Tison C; Tchobroutsky C
    Rev Prat; 1981 Jan; 31(5):345-8, 351. PubMed ID: 7466260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Betamethasone in the prevention of pulmonary hyaline membrane disease: the results and applicability of G.C. Liggins' protocol].
    Scarcella A; De Filippis A; Cascioli CF; Balletta M; Rossi E; Ciccimarra F
    Minerva Pediatr; 1983 Apr; 35(7):307-11. PubMed ID: 6346034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H
    Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hyaline membrane disease with the plasminogen urokinase combination].
    Leroux B; Rose JP; Potron G; Grun G; Droulle C; Mesmin F; Gomes H
    Nouv Presse Med; 1976 Mar; 5(11):699-702. PubMed ID: 772595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the prevention of respiratory distress syndrome of infants due to hyaline membrane disease with plasminogen.
    Ambrus CM; Choi TS; Weintraub DH; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Semin Thromb Hemost; 1975 Jul; 2(1):42-51. PubMed ID: 798269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.